1 Month Weight Loss Course (RETATRUTIDE)

Retatrutide 20 mg Multi-Use Pen

Overview
The Retatrutide 20 mg Pen is a meticulously engineered peptide delivery system for research purposes only, providing a convenient and precise method for subcutaneous administration. This pen format is pre‑filled with 20 mg of Retatrutide—a powerful synthetic peptide that acts as a triple hormone receptor agonist targeting GLP‑1, GIP, and glucagon pathways

Key Features

• Triple Agonist Mechanism: Simulates the activity of three hormones—GLP‑1, GIP, and glucagon—to promote fat burning, appetite suppression, improved insulin sensitivity, and metabolic enhancement
• Convenient Format: Delivered in a pre‑filled pen designed for ease of use, facilitating precise, once‑weekly subcutaneous injections into the arm, thigh, or abdomen
• Long-Acting Peptide: Retatrutide has an extended half-life of approximately one week (around 6 days), supporting sustained metabolic effects and reducing injection frequency
• Premium Purity & Design: Formulated for high purity and stability, the pen is equipped with sterile components and clear dosing controls—ideal for controlled research environments

Intended Use
Exclusively for laboratory research and investigational studies. Not approved or licensed for human therapeutic use, and not a medication or dietary supplement

Research Applications
Retatrutide is under thorough investigation for its potential in addressing metabolic health issues such as obesity, type 2 diabetes, and fatty liver disease, leveraging its comprehensive hormone-targeting capability

Safety & Handling

• Storage Requirements: Store according to guidelines to preserve peptide integrity—typically refrigerated or frozen, pending manufacturer’s instruction.
• Administration: Administer via subcutaneous injection following standard aseptic technique. Rotate injection sites to minimize irritation
• Side Effects: In line with similar peptide agonists, gastrointestinal effects like nausea, vomiting, diarrhea, or constipation may occur—especially during dose acclimation phases

Why Researchers Choose This Pen

• Ease of Use: Ready-to-inject pen eliminates the need for vial reconstitution and delicate dosing calculations.
• Precision: Clear, measurable doses reduce variability—an asset in experimental design.
• Efficiency: Once-weekly dosing reduces handling time and simplifies protocols.
• Advanced Mechanism: The triple-hormone agonism places Retatrutide at the forefront of metabolic peptide research.